STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
STAAR Surgical (STAA) Tops Q2 EPS by 10c, Revenues Beat; Boosts Outlook
August 1, 2018 4:06 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.09, $0.10 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $26.74 million.
Second Quarter 2018 Overview
Net Sales of $33.9 Million Up 55% from the Prior Year QuarterICL Sales Up 67% and Units Up 66% from the Prior Year QuarterOther Sales Up 18% from the Prior Year QuarterGross Margin at 74.4% of Sales from 70.5% of Sales in the Prior Year... More